-
1
-
-
34147128086
-
Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery
-
DOI 10.1097/01.sla.0000250453.34507.d3, PII 0000065820070400000014
-
Xu J, Zhong Y, Weixin N, Xinyu Q, Yanhan L, Li R, Jianhua W, Zhiping Y and Jiemin C: Preoperative hepatic and regional arterial chemotherapy in the prevention of liver metastasis after colorectal cancer surgery. Ann Surg 245: 583-590, 2007. (Pubitemid 46555662)
-
(2007)
Annals of Surgery
, vol.245
, Issue.4
, pp. 583-590
-
-
Xu, J.1
Zhong, Y.2
Weixin, N.3
Xinyu, Q.4
Yanhan, L.5
Li, R.6
Jianhua, W.7
Zhiping, Y.8
Jiemin, C.9
-
2
-
-
13444274825
-
Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases
-
DOI 10.1016/j.ejso.2004.07.030, PII S0748798304001970
-
Yedibela S, Elad L, Wein A, Dimmler A, Merkel S, Hohenberger W and Meyer T: Neoadjuvant chemotherapy does not increase postoperative complication rate after resection of colorectal liver metastases. Eur J Surg Oncol 31: 141-146, 2005. (Pubitemid 40214748)
-
(2005)
European Journal of Surgical Oncology
, vol.31
, Issue.2
, pp. 141-146
-
-
Yedibela, S.1
Elad, L.2
Wein, A.3
Dimmler, A.4
Merkel, S.5
Hohenberger, W.6
Meyer, T.7
-
3
-
-
70249110476
-
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: An international multi-institutional analysis of 1669 patients
-
de Jong MC, Pulitano C, Ribero D, Strub J, Mentha G, Schulick RD, Choti MA, Aldrighetti L, Capussotti L and Pawlik TM: Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg 250: 440-448, 2009.
-
(2009)
Ann Surg
, vol.250
, pp. 440-448
-
-
De Jong, M.C.1
Pulitano, C.2
Ribero, D.3
Strub, J.4
Mentha, G.5
Schulick, R.D.6
Choti, M.A.7
Aldrighetti, L.8
Capussotti, L.9
Pawlik, T.M.10
-
4
-
-
67649780943
-
A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases
-
Bathe OF, Ernst S, Sutherland FR, Dixon E, Butts C, Bigam D, Holland D, Porter GA, Koppel J and Dowden S: A phase II experience with neoadjuvant irinotecan (CPT-11), 5-fluorouracil (5-FU) and leucovorin (LV) for colorectal liver metastases. BMC Cancer 9: 156, 2009.
-
(2009)
BMC Cancer
, vol.9
, pp. 156
-
-
Bathe, O.F.1
Ernst, S.2
Sutherland, F.R.3
Dixon, E.4
Butts, C.5
Bigam, D.6
Holland, D.7
Porter, G.A.8
Koppel, J.9
Dowden, S.10
-
5
-
-
33646526110
-
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients
-
Mabro M, Artru P, André T, Flesch M, Maindrault-Goebel F, Landi B, Lledo G, Plantade A, Louvet C and de Gramont A: A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients. Br J Cancer 94: 1287-1292, 2006.
-
(2006)
Br J Cancer
, vol.94
, pp. 1287-1292
-
-
Mabro, M.1
Artru, P.2
André, T.3
Flesch, M.4
Maindrault-Goebel, F.5
Landi, B.6
Lledo, G.7
Plantade, A.8
Louvet, C.9
De Gramont, A.10
-
6
-
-
10744224324
-
Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer
-
Chiara S, Nobile MT, Gozza A, Taveggia P, Heouaine A, Pastrone I, Percivale PL, Lionetto R, Sanguineti O and Rosso R: Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer. Anticancer Res 24: 355-360, 2004.
-
(2004)
Anticancer Res
, vol.24
, pp. 355-360
-
-
Chiara, S.1
Nobile, M.T.2
Gozza, A.3
Taveggia, P.4
Heouaine, A.5
Pastrone, I.6
Percivale, P.L.7
Lionetto, R.8
Sanguineti, O.9
Rosso, R.10
-
7
-
-
20244385592
-
Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: Results from a multinational, randomised phase II study
-
Van Cutsem E, Dirix L, Van Laethem JL, Van Belle S, Borner M, Gonzalez Baron M, Roth A, Morant R, Joosens E, Gruia G, Sibaud D and Bleiberg H: Optimisation of irinotecan dose in the treatment of patients with metastatic colorectal cancer after 5-FU failure: results from a multinational, randomised phase II study. Br J Cancer 92: 1055-1062, 2005.
-
(2005)
Br J Cancer
, vol.92
, pp. 1055-1062
-
-
Van Cutsem, E.1
Dirix, L.2
Van Laethem, J.L.3
Van Belle, S.4
Borner, M.5
Gonzalez Baron, M.6
Roth, A.7
Morant, R.8
Joosens, E.9
Gruia, G.10
Sibaud, D.11
Bleiberg, H.12
-
8
-
-
2342469841
-
Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients
-
DOI 10.1159/000077439
-
Bajetta E, Beretta E, Di Bartolomeo M, Cortinovis D, Ferrario E, Dognini G, Toffolatti L and Buzzoni R: Efficacy of treatment with irinotecan and oxaliplatin combination in FU-resistant metastatic colorectal cancer patients. Oncology 66: 132-137, 2004. (Pubitemid 38608380)
-
(2004)
Oncology
, vol.66
, Issue.2
, pp. 132-137
-
-
Bajetta, E.1
Beretta, E.2
Di Bartolomeo, M.3
Cortinovis, D.4
Ferrario, E.5
Dognini, G.6
Toffolatti, L.7
Buzzoni, R.8
-
9
-
-
63449115959
-
Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer
-
Cao W, Yang W, Lou G, Jiang J, Geng M, Xi W, Li H, Ma T and Jin Y: Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer. Anticancer Drugs 20: 287-293, 2009.
-
(2009)
Anticancer Drugs
, vol.20
, pp. 287-293
-
-
Cao, W.1
Yang, W.2
Lou, G.3
Jiang, J.4
Geng, M.5
Xi, W.6
Li, H.7
Ma, T.8
Jin, Y.9
-
10
-
-
1342290189
-
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
-
Tournigand C, André T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C and de Gramont A: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 22: 229-237, 2004.
-
(2004)
J Clin Oncol
, vol.22
, pp. 229-237
-
-
Tournigand, C.1
André, T.2
Achille, E.3
Lledo, G.4
Flesh, M.5
Mery-Mignard, D.6
Quinaux, E.7
Couteau, C.8
Buyse, M.9
Ganem, G.10
Landi, B.11
Colin, P.12
Louvet, C.13
De Gramont, A.14
-
11
-
-
34249000361
-
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer
-
and Gruppo Oncologico Nord Ovest: the Gruppo Oncologico Nord Ovest
-
Falcone A, Ricci S, Brunetti I, Pfanner E, Allegrini G, Barbara C, Crinò L, Benedetti G, Evangelista W, Fanchini L, Cortesi E, Picone V, Vitello S, Chiara S, Granetto C, Porcile G, Fioretto L, Orlandini C, Andreuccetti M, Masi G and Gruppo Oncologico Nord Ovest: Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 25: 1670-1676, 2007.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1670-1676
-
-
Falcone, A.1
Ricci, S.2
Brunetti, I.3
Pfanner, E.4
Allegrini, G.5
Barbara, C.6
Crinò, L.7
Benedetti, G.8
Evangelista, W.9
Fanchini, L.10
Cortesi, E.11
Picone, V.12
Vitello, S.13
Chiara, S.14
Granetto, C.15
Porcile, G.16
Fioretto, L.17
Orlandini, C.18
Andreuccetti, M.19
Masi, G.20
more..
-
12
-
-
70249149719
-
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
-
Kemeny NE, Melendez FD, Capanu M, Paty PB, Fong Y, Schwartz LH, Jarnagin WR, Patel D and D'Angelica M: Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 27: 3465-3471, 2009.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3465-3471
-
-
Kemeny, N.E.1
Melendez, F.D.2
Capanu, M.3
Paty, P.B.4
Fong, Y.5
Schwartz, L.H.6
Jarnagin, W.R.7
Patel, D.8
D'Angelica, M.9
-
13
-
-
67650354362
-
Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
-
Kemeny N, Capanu M, D'Angelica M, Jarnagin W, Haviland D, Dematteo R and Fong Y: Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 20: 1236-1241, 2009.
-
(2009)
Ann Oncol
, vol.20
, pp. 1236-1241
-
-
Kemeny, N.1
Capanu, M.2
D'Angelica, M.3
Jarnagin, W.4
Haviland, D.5
Dematteo, R.6
Fong, Y.7
-
14
-
-
0020396015
-
Toxicity and response criteria of the eastern cooperative oncology group
-
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET and Carbone PP: Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5: 649-655, 1982.
-
(1982)
Am J Clin Oncol
, vol.5
, pp. 649-655
-
-
Oken, M.M.1
Creech, R.H.2
Tormey, D.C.3
Horton, J.4
Davis, T.E.5
McFadden, E.T.6
Carbone, P.P.7
-
15
-
-
0034594628
-
New guidelines to evaluate the response to treatment in solid tumors
-
Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG: New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92: 205, 2000.
-
(2000)
J Natl Cancer Inst
, vol.92
, pp. 205
-
-
Therasse, P.1
Arbuck, S.G.2
Eisenhauer, E.A.3
Wanders, J.4
Kaplan, R.S.5
Rubinstein, L.6
Verweij, J.7
Van Glabbeke, M.8
Van Oosterom, A.T.9
Christian, M.C.10
Gwyther, S.G.11
-
16
-
-
0036844353
-
Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials
-
Skitzki JJ and Chang AE: Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 11: 123-135, 2002.
-
(2002)
Surg Oncol
, vol.11
, pp. 123-135
-
-
Skitzki, J.J.1
Chang, A.E.2
-
17
-
-
0345447199
-
An update on hepatic arterial infusion chemotherapy for colorectal cancer
-
Cohen AD and Kemeny NE: An update on hepatic arterial infusion chemotherapy for colorectal cancer. Oncologist 5: 553-566, 2003.
-
(2003)
Oncologist
, vol.5
, pp. 553-566
-
-
Cohen, A.D.1
Kemeny, N.E.2
-
18
-
-
0036928276
-
Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: A dose-finding study in patients with advanced gastrointestinal malignancies
-
Comella P, Casaretti R, De Rosa V, Avallone A, Izzo F, Fiore F, Lapenta L and Comella G: Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. Ann Oncol 13: 1874-1881, 2002.
-
(2002)
Ann Oncol
, vol.13
, pp. 1874-1881
-
-
Comella, P.1
Casaretti, R.2
De Rosa, V.3
Avallone, A.4
Izzo, F.5
Fiore, F.6
Lapenta, L.7
Comella, G.8
-
19
-
-
33645309877
-
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs. FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): A multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG)
-
Souglakos J, Androulakis N, Syrigos K, Polyzos A, Ziras N, Athanasiadis A, Kakolyris S, Tsousis S, Kouroussis Ch, Vamvakas L, Kalykaki A, Samonis G, Mavroudis D and Georgoulias V: FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs. FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG). Br J Cancer 94: 798-805, 2006.
-
(2006)
Br J Cancer
, vol.94
, pp. 798-805
-
-
Souglakos, J.1
Androulakis, N.2
Syrigos, K.3
Polyzos, A.4
Ziras, N.5
Athanasiadis, A.6
Kakolyris, S.7
Tsousis, S.8
Kouroussis, Ch.9
Vamvakas, L.10
Kalykaki, A.11
Samonis, G.12
Mavroudis, D.13
Georgoulias, V.14
-
20
-
-
38349091716
-
Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study
-
and Spanish Cooperative Group for Digestive Tumor Therapy
-
Abad A, Massuti B, Antón A, Vega ME, Yuste AL, Marcuello E, Manzano JL, Alonso V, Carrato A, Martinez-Villacampa M, Tabernero J, Aranda E, Rivera F, Díaz-Rubio E and Spanish Cooperative Group for Digestive Tumor Therapy: Colorectal cancer metastasis resectability after treatment with the combination of oxaliplatin, irinotecan and 5-fluorouracil. Final results of a phase II study. Acta Oncol 47: 286-292, 2008.
-
(2008)
Acta Oncol
, vol.47
, pp. 286-292
-
-
Abad, A.1
Massuti, B.2
Antón, A.3
Vega, M.E.4
Yuste, A.L.5
Marcuello, E.6
Manzano, J.L.7
Alonso, V.8
Carrato, A.9
Martinez-Villacampa, M.10
Tabernero, J.11
Aranda, E.12
Rivera, F.13
Díaz-Rubio, E.14
-
21
-
-
34548476513
-
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group
-
and European Colorectal Metastases Treatment Group
-
Nordlinger B, Van Cutsem E, Rougier P, Könne CH, Ychou M, Sobrero A, Adam R, Arvidsson D, Carrato A, Georgoulias V, Giuliante F, Glimelius B, Golling M, Gruenberger T, Tabernero J, Wasan H, Poston G and European Colorectal Metastases Treatment Group: Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. Eur J Cancer 43: 2037-2045, 2007.
-
(2007)
Eur J Cancer
, vol.43
, pp. 2037-2045
-
-
Nordlinger, B.1
Van Cutsem, E.2
Rougier, P.3
Könne, C.H.4
Ychou, M.5
Sobrero, A.6
Adam, R.7
Arvidsson, D.8
Carrato, A.9
Georgoulias, V.10
Giuliante, F.11
Glimelius, B.12
Golling, M.13
Gruenberger, T.14
Tabernero, J.15
Wasan, H.16
Poston, G.17
-
22
-
-
0036605387
-
Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: A multicenter phase II trial
-
Souglakos J, Mavroudis D, Kakolyris S, Kourousis Ch, Vardakis N, Androulakis N, Agelaki S, Kalbakis K, Tsetis D, Athanasiadis N, Samonis G and Georgoulias V: Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial. J Clin Oncol 20: 2651-2657, 2002.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2651-2657
-
-
Souglakos, J.1
Mavroudis, D.2
Kakolyris, S.3
Kourousis, Ch.4
Vardakis, N.5
Androulakis, N.6
Agelaki, S.7
Kalbakis, K.8
Tsetis, D.9
Athanasiadis, N.10
Samonis, G.11
Georgoulias, V.12
-
23
-
-
57049164995
-
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy
-
Nobili S, Checcacci D, Filippelli F, Del Buono S, Mazzocchi V, Mazzei T and Mini E: Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy. J Chemother 20: 622-631, 2008.
-
(2008)
J Chemother
, vol.20
, pp. 622-631
-
-
Nobili, S.1
Checcacci, D.2
Filippelli, F.3
Del Buono, S.4
Mazzocchi, V.5
Mazzei, T.6
Mini, E.7
|